HGH Human Growth Hormone Company Profile

05:31 EDT 22nd June 2018 | BioPortfolio



17008-90th AvenueSuite #607
T5T 1L6


Fax: (888) 442-5999

News Articles [979 Associated News Articles listed on BioPortfolio]

Human Growth Hormone (hGH) Market, 2025 - Key Players are Pfizer, Merck & Co. Eli Lilly and Company, Genentech, Novo Nordisk, Sandoz International, Ferring and Ipsen

DUBLIN, Jan. 24, 2018 /PRNewswire/ -- The "Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, S...

Somatropin approved for use in adults with GH deficiency

The FDA recently approved expanding the indication for Ferring’s subcutaneous somatropin 5 mg and 10 mg recombinant human growth hormone to include replacement of growth hormone in adults with growt...

Global Human Growth Hormone (hGH) Market Analysis and Forecasts 2014-2017 & 2025: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA –

DUBLIN–(BUSINESS WIRE)–The “Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SG...

BRIEF—Ferring adds new indication for replacement growth hormone

Ferring Pharmaceuticals has been awarded US FDA approval for its Zomacton recombinant human growth hormone…

Ferring's ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Defic...

Ferring today announced that the FDA has approved ZOMACTON for Injection 5 mg and 10 mg recombinant human growth hormone indicated for replacement of GH in adults with GH deficiency.

Long-term Safety of Growth Hormone

What does the current data tell us about the long-term safety of recombinant human growth hormone treatment? Clinical Endocrinology

Ascendis Pharma Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone for Pediatric Growth Hormone Deficiency

COPENHAGEN, Denmark, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet...

FDA OKs Ferring's growth hormone deficiency therapy in adults

The FDA approved Ferring's Zomacton, or somatropin [rDNA origin], injection for the replacement of growth hormone in adult pa -More- 

Drugs and Medications [100 Associated Drugs and Medications listed on BioPortfolio]

Saizen [EMD Serono, Inc.]

Saizen [somatropin (rDNA origin) for injection] For subcutaneous or intramuscular injection

Desmopressin acetate [American Health Packaging]


Zorbtive [EMD Serono, Inc.]

Zorbtive [somatropin (rDNA origin) for injection]

Octreotide acetate [TEVA Parenteral Medicines, Inc.]

Octreotide Acetate Injection

Octreotide acetate [Sandoz Inc]

Octreotide Acetate Injection

PubMed Articles [4519 Associated PubMed Articles listed on BioPortfolio]

The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease.

was to investigate the coincidence of growth hormone deficiency (GHD) and celiac disease (CD) or inflammatory bowel disease (IBD) in patients referred for short stature, and to evaluate the baseline a...

Interactions between the growth hormone and cytokines - A review.

Numerous reports on the interactions between the immune and endocrine systems, especially growth hormone axis, can be found in the literature. Growth hormone acts mainly indirectly through insulin-lik...

Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency.

Reports on the association between growth hormone deficiency (GHD) and cardiovascular risk factors in children are limited. We aim to investigate the effect of different doses of rhGH therapy on blood...

Growth and growth hormone: recent papers on efficacy and adverse effects of growth hormone and World Health Organisation growth standards.

Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency.

Data about the impact of growth hormone treatment (GHT) on insulin sensitivity in children are quite controversial, due to the different surrogate indices that have been used.

Clinical Trials [7051 Associated Clinical Trials listed on BioPortfolio]

Safety, PK/PD and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

A six month study of ACP-001, a long-acting growth hormone product, versus standard human growth hormone therapy. ACP-001 will be given once-a-week, standard human growth hormone (hGH) wil...

Growth Hormone Administration and the Human Immune System - II

This study will investigate whether growth hormone, administered in a physiological or pulsatile (pulse-like) fashion, can elicit relevant changes in the human immune system while at the s...

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

The purpose of this study is to investigate the effect of low-dose human growth hormone therapy on immune status and fat morphology.

D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome

The protein polymorphism of the growth hormone receptor characterized by the genomic deletion of exon 3 has been linked to the magnitude of the first-year-growth response to growth hormone...

Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease

Circulating concentrations of cytokines, such as leptin, tumor necrosis factor-alpha and interleukins 1 and 6 are increased in patients with chronic kidney disease (CKD). In light of the i...

Companies [1873 Associated Companies listed on BioPortfolio]


BresaGen is based in Adelaide, South Australiaand operates a cGMP facility with the capacity to manufacture recombinant proteins and peptides. The Company has human therapeutic API candidates and offe...

HGH Human Growth Hormone


Genexine, Inc.

Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical...

Globe Laboratories

Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists...

Trophogen, Inc

Trophogen, Inc. is a biotechnology company founded in 2001 with series A funding from Toucan Capital, focusing on the development of high affinity glycoprotein hormone and related growth factor analog...

More Information about "HGH Human Growth Hormone" on BioPortfolio

We have published hundreds of HGH Human Growth Hormone news stories on BioPortfolio along with dozens of HGH Human Growth Hormone Clinical Trials and PubMed Articles about HGH Human Growth Hormone for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HGH Human Growth Hormone Companies in our database. You can also find out about relevant HGH Human Growth Hormone Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record